Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.64 |
| ▸ | LCK | P06239 | 1/20 | 0.64 |
| ▸ | FYN | P06241 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.33 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL1814460 | 1.00 | — | — | |
| Acetic Acid SCHEMBL11393720 | 1.00 | FFAR3 (0.64) | FFAR3LCKFYNTSHRLMNA | |
| Acetic Acid SCHEMBL27984532 | 0.96 | — | — | |
| Acetic Acid SCHEMBL11332773 | 0.96 | — | — | |
| Acetic Acid SCHEMBL19923337 | 0.92 | FFAR3 (0.54) | FFAR3LCKFYNTSHRLMNA | |
| Acetic Acid SCHEMBL28535319 | 0.92 | — | — | |
| Acetic Acid SCHEMBL28318602 | 0.92 | FFAR3 (0.54) | FFAR3LCKFYNTSHRLMNA | |
| Acetic Acid SCHEMBL28180219 | 0.89 | FFAR3 (0.50) | FFAR3LCKFYNTSHRLMNA | |
| Pyruvate SCHEMBL9721321 | 0.89 | FFAR3 (0.50) | FFAR3LCKFYNTSHRLMNA | |
| Bicarbonate SCHEMBL8827978 | 0.86 | TSHR (0.60) | FFAR3LCKFYNTSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7750199-B1 | Kit systems for granulated decontamination formulations | SANDIA CORPORATION (US) | 2010-07-06 | — | — | US | claimed |
| WO-2005089100-A2 | DECONTAMINATION FORMULATIONS FOR DISINFECTION AND STERILIZATION | SANDIA CORPORATION (US) | 2005-09-29 | — | — | WO | claimed |
| WO-2005057588-A2 | GRANULATED DECONTAMINATION FORMULATIONS | SANDIA CORPORATION (US) | 2005-06-23 | — | — | WO | claimed |
| US-20050109981-A1 | Decontamination formulations for disinfection and sterilization | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC | 2005-05-26 | — | — | US | claimed |
| US-7750199-B1 | Kit systems for granulated decontamination formulations | SANDIA CORPORATION (US) | 2010-07-06 | — | — | US | disclosed |
| US-20070249509-A1 | GRANULATED DECONTAMINATION FORMULATIONS | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC | 2007-10-25 | — | — | US | disclosed |
| US-7276468-B1 | Granulated decontamination formulations | SANDIA CORPORATION (US) | 2007-10-02 | — | — | US | disclosed |
| US-7271137-B2 | Decontamination formulations for disinfection and sterilization | SANDIA CORPORATION (US) | 2007-09-18 | — | — | US | disclosed |
| US-7125497-B1 | Reactive formulations for a neutralization of toxic industrial chemicals | SANDIA CORPORATION (US) | 2006-10-24 | — | — | US | disclosed |
| WO-2005089100-A2 | DECONTAMINATION FORMULATIONS FOR DISINFECTION AND STERILIZATION | SANDIA CORPORATION (US) | 2005-09-29 | — | — | WO | disclosed |
| WO-2005057588-A2 | GRANULATED DECONTAMINATION FORMULATIONS | SANDIA CORPORATION (US) | 2005-06-23 | — | — | WO | disclosed |
| US-20050109981-A1 | Decontamination formulations for disinfection and sterilization | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC | 2005-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050109981-A1 | Decontamination formulations for disinfection and sterilization | CAT, PRKDC, PRKACG | FFAR3 3283/4885LCK 3711/4885FYN 4032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.